Page last updated: 2024-11-08

aspartic acid and Diabetes Mellitus, Type 1

aspartic acid has been researched along with Diabetes Mellitus, Type 1 in 54 studies

Aspartic Acid: One of the non-essential amino acids commonly occurring in the L-form. It is found in animals and plants, especially in sugar cane and sugar beets. It may be a neurotransmitter.
aspartic acid : An alpha-amino acid that consists of succinic acid bearing a single alpha-amino substituent
L-aspartic acid : The L-enantiomer of aspartic acid.

Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

Research Excerpts

ExcerptRelevanceReference
"The response of the subjects with IDDM was similar to that of the normal subjects."2.70Effect of protein restriction on (15)N transfer from dietary [(15)N]alanine and [(15)N]Spirulina platensis into urea. ( Hamadeh, MJ; Hoffer, LJ, 2001)
"Forty-eight IDDM patients and 59 nondiabetic unrelated control subjects were recruited from the population in Taiwan."2.67HLA-DQB1 codon 57 and IDDM in Chinese living in Taiwan. ( Chen, KH; Chuang, LM; Hsieh, RP; Hu, CY; Jou, TS; Lee, JS; Lin, BJ; Tai, TY; Tsai, WY; Wu, HP, 1994)
"In 25 children, 6-14 years of age, with type 1 diabetes across 3 sites, we acquired T1WI and axial 2D MRSI along with phantom studies to calibrate scanner effects."1.91Exploratory Multisite MR Spectroscopic Imaging Shows White Matter Neuroaxonal Loss Associated with Complications of Type 1 Diabetes in Children. ( Alonso, GT; Anderson, AW; Cai, LY; Ghetti, S; Glaser, N; Gwal, K; Jaser, SS; Jones, RS; Jordan, LC; Juvera, J; Kang, H; Landman, BA; Lee, CA; LeStourgeon, LM; Mahon, A; Ozturk, A; Patel, NJ; Pruthi, S; Rewers, A; Rewers, MJ; Taki, I; Tanase, C, 2023)
"DKA at type 1 diabetes diagnosis results in morphologic and functional brain changes."1.40Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children. ( Cameron, FJ; Finney, K; Inder, TE; Jennings, J; Koves, I; Mackay, M; Nadebaum, C; Neil, JJ; Northam, EA; Scratch, SE; Wellard, RM, 2014)
"The impact of type 1 diabetes mellitus (T1DM) on a comprehensive neurochemical profile of the human brain has not been reported yet."1.39Neurochemical profile of patients with type 1 diabetes measured by ¹H-MRS at 4 T. ( Eberly, LE; Kumar, AF; Mangia, S; Moheet, AA; Roberts, RJ; Seaquist, ER; Tkáč, I, 2013)
"A total of 83% of participants had type 2 diabetes."1.33T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study. ( Beck, SR; Bowden, DW; Burdon, KP; Freedman, BI; Langefeld, CD; Liu, Y; Rich, SS; Wagenknecht, LE, 2005)
"Autoimmune diabetes is a complex, multifactorial disease caused by the interaction of genetic and environmental factors."1.33[HLA DQB1 genotyping in latent autoimmune diabetes of adults (LADA)]. ( Caputo, M; Cedola, N; Cerrone, GE; Frechtel, GD; Gonzalez, C; Lopez, AP; Mazza, C; Puchulu, FM; Targovnik, HM, 2005)
"To clarify the genetic background of IDDMS, we analyzed HLA-DRB1, -DQB1 and -DQA1 alleles, phenotypes, and genotypes and compared them with acute-onset type 1 diabetes, non-insulin-dependent diabetes mellitus (NIDDM), and control subjects."1.33Slowly progressing form of type 1 diabetes mellitus in children: genetic analysis compared with other forms of diabetes mellitus in Japanese children. ( Kazahari, M; Kikuchi, N; Koike, A; Matsuura, N; Nomoto, K; Ohtsu, S; Takubo, N; Yokota, F, 2005)
"Myo-inositol was even more elevated in patients with polyneuropathy (p = 0."1.32Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy. ( Feuerbach, S; Fründ, R; Geissler, A; Schölmerich, J; Zietz, B, 2003)
"Eleven IDDM patients with no history of severe hypoglycemia (group A) were compared with 11 IDDM patients who had a history of five or more episodes of severe hypoglycemia (group B)."1.30Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. ( Best, JJ; Deary, IJ; Frier, BM; Perros, P; Sellar, RJ, 1997)
"By contrast, IDDM patients with no Ab showed no particular association with HLA class II allele although they had clinical and metabolic characteristics similar to that of Ab-positive subjects."1.30Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects. ( Boitard, C; Caillat-Zucman, S; Djilali-Saiah, I; Dubois-Laforgue, D; Timsit, J, 1997)
"Susceptibility and resistance to type 1 diabetes are associated with MHC class II alleles that carry non-Asp and Asp at residue 57 of their beta chain respectively."1.30The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules. ( Buus, S; Holm, A; Johansen, BH; Paulsen, G; Quarsten, H; Sollid, LM; Thorpe, CJ, 1998)
"Sixty-nine IDDM patients and 47 healthy controls in a Southern Chinese population were HLA-DQB1 genotyped by one-step sequence specific polymerase chain reaction (ssPCR)."1.30Contribution of the absence of aspartic acid at position 57 of the HLA-DQ beta chain to predisposition to insulin-dependent diabetes mellitus in a southern Chinese population. ( Cheng, H; Fu, Z; Yan, T; Zhang, S; Zhong, G, 1998)
"In human IDDM it has been suggested that the presence of an aspartate at position 57 of the DQ beta-chain might be important in determining resistance to development of IDDM."1.29Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus. ( Chandler, P; Day, S; Hutchings, PR; Kioussis, D; Lund, T; O'Reilly, L; Ozegbe, P; Picard, J; Quartey-Papafio, R; Simpson, E, 1995)
"HLA-DQ beta alleles are genetic susceptibility markers in New Zealand, and other Caucasian populations."1.29HLA-DQ beta typing and non-Asp57 alleles in IDDM and nondiabetic subjects in New Zealand. ( Brown, LJ; Forbes, LV; Scott, RS, 1993)
"HLA-DQ beta 1 alleles may be genetic susceptibility markers for IDDM in the Senegalese population, as they are in Caucasian populations."1.29HLA-DQ beta 1 typing and non-Asp57 alleles in the aborigine population of Senegal. ( Chauffert, M; Chevenne, D; Cisse, A; Michel, S; Parfait, B; Trivin, F, 1995)
"MHC associations with IDDM in the Korean population were studied to investigate genetic susceptibility to this disorder."1.29Role of HLA class II alleles in Korean patients with IDDM. ( Chung, YS; Fugisawa, T; Fujisawa, T; Huh, KB; Ikegami, H; Kim, DH; Kim, KR; Kim, YS; Lee, DS; Lee, EJ; Lee, HC; Lim, SK; Ogihara, T; Park, JO; Park, SW, 1996)
"Thus, susceptibility to Type 1 diabetes in Spanish patients is associated, quantitatively, with non-Asp 57 DQ beta and Arg 52 DQ alpha alleles."1.28Susceptibility to type 1 (insulin-dependent) diabetes mellitus in Spanish patients correlates quantitatively with expression of HLA-DQ alpha Arg 52 and HLA-DQ beta non-Asp 57 alleles. ( Bertera, S; Chantres, MT; Dorman, JS; Gutierrez-Lopez, MD; Serrano-Rios, M; Trucco, M; Vavassori, C, 1992)
"Insulin-dependent diabetes mellitus (IDDM) in Caucasians is closely associated with the HLA-DQ gene, especially the residue 57 of the DQ beta chain."1.28Aspartic acid at position 57 of the HLA-DQ beta chain is not protective against insulin-dependent diabetes mellitus in Japanese people. ( Cha, T; Ikegami, H; Noma, Y; Ogihara, T; Shima, K; Tahara, Y; Yamato, E, 1990)
"Thirty-five (48."1.28High frequency of aspartic acid at position 57 of HLA-DQ beta-chain in Japanese IDDM patients and nondiabetic subjects. ( Awata, T; Iwamoto, Y; Juji, T; Kanazawa, Y; Kuzuya, T; Matsuda, A; Okuyama, M, 1990)

Research

Studies (54)

TimeframeStudies, this research(%)All Research%
pre-19905 (9.26)18.7374
1990's28 (51.85)18.2507
2000's13 (24.07)29.6817
2010's6 (11.11)24.3611
2020's2 (3.70)2.80

Authors

AuthorsStudies
Cai, LY1
Tanase, C1
Anderson, AW1
Patel, NJ1
Lee, CA1
Jones, RS1
LeStourgeon, LM1
Mahon, A1
Taki, I1
Juvera, J1
Pruthi, S1
Gwal, K1
Ozturk, A1
Kang, H1
Rewers, A1
Rewers, MJ1
Alonso, GT1
Glaser, N1
Ghetti, S1
Jaser, SS1
Landman, BA1
Jordan, LC1
Crawford, SA1
Groegler, J1
Dang, M1
Michel, C1
Powell, RL1
Hohenstein, AC1
Reyes, K1
Haskins, K1
Wiles, TA1
Delong, T1
Hansen, TM1
Brock, B1
Juhl, A1
Drewes, AM1
Vorum, H1
Andersen, CU1
Jakobsen, PE1
Karmisholt, J1
Frøkjær, JB1
Brock, C1
Mangia, S1
Kumar, AF1
Moheet, AA1
Roberts, RJ1
Eberly, LE1
Seaquist, ER1
Tkáč, I1
Cameron, FJ1
Scratch, SE1
Nadebaum, C1
Northam, EA1
Koves, I1
Jennings, J1
Finney, K1
Neil, JJ1
Wellard, RM2
Mackay, M1
Inder, TE1
Zhang, H1
Huang, M1
Gao, L1
Lei, H1
Kato, I1
Oya, T1
Suzuki, H1
Takasawa, K1
Ichsan, AM1
Nakada, S1
Ishii, Y1
Shimada, Y1
Sasahara, M1
Tobe, K1
Takasawa, S1
Okamoto, H1
Hiraga, K1
Wootton-Gorges, SL1
Buonocore, MH1
Caltagirone, RA1
Kuppermann, N1
Glaser, NS1
Wang, WT1
Lee, P1
Yeh, HW1
Smirnova, IV1
Choi, IY1
Geissler, A1
Fründ, R1
Schölmerich, J1
Feuerbach, S1
Zietz, B1
Rudofsky, G1
Reismann, P1
Witte, S1
Humpert, PM1
Isermann, B1
Chavakis, T1
Tafel, J1
Nosikov, VV1
Hamann, A1
Nawroth, P1
Bierhaus, A1
Yu, J1
Shin, CH1
Yang, SW1
Park, MH1
Eisenbarth, GS1
Liu, Y1
Burdon, KP1
Langefeld, CD1
Beck, SR1
Wagenknecht, LE1
Rich, SS1
Bowden, DW1
Freedman, BI1
Sarac, K1
Akinci, A1
Alkan, A1
Aslan, M1
Baysal, T1
Ozcan, C1
Caputo, M1
Cerrone, GE1
Lopez, AP1
Gonzalez, C1
Mazza, C1
Cedola, N1
Puchulu, FM1
Targovnik, HM1
Frechtel, GD1
Rankins, D1
Cameron, F1
McDonnell, C1
Northam, E1
Ohtsu, S1
Takubo, N1
Kazahari, M1
Nomoto, K1
Yokota, F1
Kikuchi, N1
Koike, A1
Matsuura, N1
Quartey-Papafio, R1
Lund, T1
Chandler, P1
Picard, J1
Ozegbe, P1
Day, S1
Hutchings, PR1
O'Reilly, L1
Kioussis, D1
Simpson, E1
Sanjeevi, CB1
Lybrand, TP1
DeWeese, C1
Landin-Olsson, M1
Kockum, I1
Dahlquist, G1
Sundkvist, G1
Stenger, D1
Lernmark, A1
Chuang, LM1
Jou, TS1
Hu, CY1
Wu, HP1
Tsai, WY1
Lee, JS1
Hsieh, RP1
Chen, KH1
Tai, TY1
Lin, BJ1
Maruyama, T1
Shimada, A1
Kasuga, A1
Kasatani, T1
Ozawa, Y1
Ishii, M1
Takei, I1
Suzuki, Y1
Kobayashi, A1
Takeda, S1
Forbes, LV1
Brown, LJ1
Scott, RS1
Patel, P1
Lo, YM1
Bell, JI1
Wainscoat, JS1
Chauffert, M1
Cisse, A1
Chevenne, D1
Parfait, B1
Michel, S1
Trivin, F1
Lee, HC1
Ikegami, H2
Fujisawa, T1
Ogihara, T2
Park, SW1
Chung, YS1
Park, JO1
Lee, EJ1
Lim, SK1
Kim, KR1
Huh, KB1
Kim, YS1
Lee, DS1
Kim, DH1
Fugisawa, T1
Perros, P1
Deary, IJ1
Sellar, RJ1
Best, JJ1
Frier, BM1
Antoniou, AN1
Elliott, J1
Rosmarakis, E1
Dyson, PJ1
Dubois-Laforgue, D1
Timsit, J1
Djilali-Saiah, I1
Boitard, C1
Caillat-Zucman, S1
Bowen, J1
Richards, T1
Maravilla, K1
Quarsten, H1
Paulsen, G1
Johansen, BH1
Thorpe, CJ1
Holm, A1
Buus, S1
Sollid, LM1
Bartnes, K1
Li, X1
Briand, JP1
Travers, PJ1
Hannestad, K1
Corper, AL1
Stratmann, T1
Apostolopoulos, V1
Scott, CA1
Garcia, KC1
Kang, AS1
Wilson, IA1
Teyton, L1
Ettinger, RA1
Liu, AW1
Nepom, GT1
Kwok, WW1
Zhang, S1
Cheng, H1
Fu, Z1
Zhong, G1
Yan, T1
Weintrob, N1
Sprecher, E1
Israel, S1
Pinhas-Hamiel, O1
Kwon, OJ1
Bloch, K1
Abramov, N1
Arbel, A1
Josefsberg, Z1
Brautbar, C1
Vardi, P1
Hamadeh, MJ1
Hoffer, LJ1
Trucco, M6
Awata, T2
Kuzuya, T2
Matsuda, A2
Iwamoto, Y2
Kanazawa, Y2
Gutierrez-Lopez, MD1
Bertera, S1
Chantres, MT1
Vavassori, C1
Dorman, JS3
Serrano-Rios, M1
Martinez-Laso, J1
Vicario, JL1
Corell, A1
Martin-Villa, JM1
Morales, P1
Lledó, G1
Arnaiz-Villena, A1
Ju, LY1
Sun, YP1
Semana, G1
Gu, XF1
Krishnamoorty, R1
Fauchet, R1
Charron, D1
Reijonen, H1
Ilonen, J1
Knip, M1
Akerblom, HK1
Boehm, BO2
Scherbaum, WA1
Schöffling, K2
Kühnl, P1
Althoff, P1
Manfras, B2
Usadel, KH1
Tahara, Y1
Cha, T1
Yamato, E1
Noma, Y1
Shima, K1
Olerup, O1
Smith, CI1
Hammarström, L1
Rosak, C1
Miyazaki, T1
Uno, M1
Uehira, M1
Kikutani, H1
Kishimoto, T1
Kimoto, M1
Nishimoto, H1
Miyazaki, J1
Yamamura, K1
Okuyama, M1
Juji, T1
Vallet-Colom, I1
Lévy-Marchal, C1
Zarrouk, D1
Tichet, J1
Krishnamoorthy, R1
Czernichow, P1
Elion, J1
Yamagata, K1
Nakajima, H1
Hanafusa, T1
Noguchi, T1
Miyazaki, A1
Miyagawa, J1
Sada, M1
Amemiya, H1
Tanaka, T1
Kono, N1
Bao, MZ1
Wang, JX1
Rønningen, KS1
Iwe, T1
Halstensen, TS1
Spurkland, A1
Thorsby, E1
Rusting, R1
Morel, PA1
Todd, JA1
McDevitt, HO1

Reviews

1 review available for aspartic acid and Diabetes Mellitus, Type 1

ArticleYear
To be or not to be Asp 57, that is the question.
    Diabetes care, 1992, Volume: 15, Issue:5

    Topics: Amino Acid Sequence; Aspartic Acid; Child; Diabetes Mellitus, Type 1; Genetic Markers; Haplotypes; H

1992

Trials

2 trials available for aspartic acid and Diabetes Mellitus, Type 1

ArticleYear
HLA-DQB1 codon 57 and IDDM in Chinese living in Taiwan.
    Diabetes care, 1994, Volume: 17, Issue:8

    Topics: Adolescent; Alleles; Aspartic Acid; China; Codon; Diabetes Mellitus, Type 1; Gene Frequency; Genotyp

1994
Effect of protein restriction on (15)N transfer from dietary [(15)N]alanine and [(15)N]Spirulina platensis into urea.
    American journal of physiology. Endocrinology and metabolism, 2001, Volume: 281, Issue:2

    Topics: Alanine; Aspartic Acid; Bacterial Proteins; Diabetes Mellitus, Type 1; Diet, Protein-Restricted; Fem

2001

Other Studies

51 other studies available for aspartic acid and Diabetes Mellitus, Type 1

ArticleYear
Exploratory Multisite MR Spectroscopic Imaging Shows White Matter Neuroaxonal Loss Associated with Complications of Type 1 Diabetes in Children.
    AJNR. American journal of neuroradiology, 2023, Volume: 44, Issue:7

    Topics: Aspartic Acid; Brain; Child; Choline; Creatine; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Gl

2023
Hybrid insulin peptide isomers spontaneously form in pancreatic beta-cells from an aspartic anhydride intermediate.
    The Journal of biological chemistry, 2023, Volume: 299, Issue:11

    Topics: Animals; Aspartic Acid; Diabetes Mellitus, Type 1; Humans; In Vitro Techniques; Insulin; Insulin-Sec

2023
Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes.
    Journal of diabetes and its complications, 2019, Volume: 33, Issue:4

    Topics: Adult; Aspartic Acid; Brain; Brain Chemistry; Case-Control Studies; Diabetes Mellitus, Type 1; Diabe

2019
Neurochemical profile of patients with type 1 diabetes measured by ¹H-MRS at 4 T.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2013, Volume: 33, Issue:5

    Topics: Adult; Aspartic Acid; Brain; Diabetes Mellitus, Type 1; Female; Glutamic Acid; Humans; Magnetic Reso

2013
Neurological consequences of diabetic ketoacidosis at initial presentation of type 1 diabetes in a prospective cohort study of children.
    Diabetes care, 2014, Volume: 37, Issue:6

    Topics: Adolescent; Aspartic Acid; Brain; Child; Cognition Disorders; Diabetes Mellitus, Type 1; Diabetic Ke

2014
Region-specific cerebral metabolic alterations in streptozotocin-induced type 1 diabetic rats: an in vivo proton magnetic resonance spectroscopy study.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2015, Volume: 35, Issue:11

    Topics: Animals; Aspartic Acid; Blood Glucose; Brain Chemistry; Corpus Striatum; Diabetes Mellitus, Experime

2015
A novel model of insulin-dependent diabetes with renal and retinal lesions by transgenic expression of CaMKIIalpha (Thr286Asp) in pancreatic beta-cells.
    Diabetes/metabolism research and reviews, 2008, Volume: 24, Issue:6

    Topics: Amino Acid Substitution; Animals; Animals, Genetically Modified; Aspartic Acid; Calcium-Calmodulin-D

2008
Progressive decrease in N-acetylaspartate/Creatine ratio in a teenager with type 1 diabetes and repeated episodes of ketoacidosis without clinically apparent cerebral edema: Evidence for permanent brain injury.
    AJNR. American journal of neuroradiology, 2010, Volume: 31, Issue:4

    Topics: Adolescent; Aspartic Acid; Basal Ganglia; Blood Glucose; Brain; Brain Damage, Chronic; Brain Edema;

2010
Effects of acute and chronic hyperglycemia on the neurochemical profiles in the rat brain with streptozotocin-induced diabetes detected using in vivo ¹H MR spectroscopy at 9.4 T.
    Journal of neurochemistry, 2012, Volume: 121, Issue:3

    Topics: Acute Disease; Algorithms; Animals; Aspartic Acid; Biological Transport, Active; Blood Glucose; Bloo

2012
Alterations of cerebral metabolism in patients with diabetes mellitus studied by proton magnetic resonance spectroscopy.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2003, Volume: 111, Issue:7

    Topics: Adult; Aspartic Acid; Blood Glucose; Brain; Chlorides; Choline; Creatinine; Diabetes Mellitus, Type

2003
Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes.
    Diabetes care, 2004, Volume: 27, Issue:1

    Topics: Amino Acid Substitution; Aspartic Acid; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabet

2004
Analysis of children with type 1 diabetes in Korea: high prevalence of specific anti-islet autoantibodies, immunogenetic similarities to Western populations with "unique" haplotypes, and lack of discrimination by aspartic acid at position 57 of DQB.
    Clinical immunology (Orlando, Fla.), 2004, Volume: 113, Issue:3

    Topics: Adolescent; Adult; Aspartic Acid; Autoantibodies; Child; Child, Preschool; Diabetes Mellitus, Type 1

2004
T-786C polymorphism of the endothelial nitric oxide synthase gene is associated with albuminuria in the diabetes heart study.
    Journal of the American Society of Nephrology : JASN, 2005, Volume: 16, Issue:4

    Topics: Aged; Albuminuria; Aspartic Acid; Creatinine; Cysteine; Diabetes Mellitus, Type 1; Diabetes Mellitus

2005
Brain metabolite changes on proton magnetic resonance spectroscopy in children with poorly controlled type 1 diabetes mellitus.
    Neuroradiology, 2005, Volume: 47, Issue:7

    Topics: Adolescent; Adult; Aspartic Acid; Brain; Case-Control Studies; Child; Choline; Creatinine; Diabetes

2005
[HLA DQB1 genotyping in latent autoimmune diabetes of adults (LADA)].
    Medicina, 2005, Volume: 65, Issue:3

    Topics: Adolescent; Adult; Age of Onset; Argentina; Aspartic Acid; Autoimmune Diseases; Case-Control Studies

2005
The impact of acute hypoglycemia on neuropsychological and neurometabolite profiles in children with type 1 diabetes.
    Diabetes care, 2005, Volume: 28, Issue:11

    Topics: Acute Disease; Aspartic Acid; Attention; Blood Glucose; Child; Diabetes Mellitus, Type 1; Female; Fo

2005
Slowly progressing form of type 1 diabetes mellitus in children: genetic analysis compared with other forms of diabetes mellitus in Japanese children.
    Pediatric diabetes, 2005, Volume: 6, Issue:4

    Topics: Age of Onset; Arginine; Asian People; Aspartic Acid; Autoantibodies; Case-Control Studies; Child; Ch

2005
Aspartate at position 57 of nonobese diabetic I-Ag7 beta-chain diminishes the spontaneous incidence of insulin-dependent diabetes mellitus.
    Journal of immunology (Baltimore, Md. : 1950), 1995, May-15, Volume: 154, Issue:10

    Topics: Amino Acid Sequence; Animals; Antigen-Presenting Cells; Aspartic Acid; Base Sequence; Cyclophosphami

1995
Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of IDDM. Members of the Swedish Childhood Diabetes Study.
    Diabetes, 1995, Volume: 44, Issue:1

    Topics: Adolescent; Amino Acid Sequence; Amino Acids; Arginine; Aspartic Acid; Child; Child, Preschool; Diab

1995
Analysis of MHC class II antigens in Japanese IDDM by a novel HLA-typing method, hybridization protection assay.
    Diabetes research and clinical practice, 1994, Volume: 23, Issue:2

    Topics: Adolescent; Adult; Aged; Alleles; Arginine; Aspartic Acid; Child; Child, Preschool; Diabetes Mellitu

1994
HLA-DQ beta typing and non-Asp57 alleles in IDDM and nondiabetic subjects in New Zealand.
    Diabetes care, 1993, Volume: 16, Issue:8

    Topics: Alleles; Amino Acid Sequence; Aspartic Acid; Diabetes Mellitus, Type 1; Disease Susceptibility; Gene

1993
Rapid HLA typing by multiplex amplification refractory mutation system.
    Journal of clinical pathology, 1993, Volume: 46, Issue:12

    Topics: Alleles; Arginine; Aspartic Acid; Base Sequence; Diabetes Mellitus, Type 1; Disease Susceptibility;

1993
HLA-DQ beta 1 typing and non-Asp57 alleles in the aborigine population of Senegal.
    Diabetes care, 1995, Volume: 18, Issue:5

    Topics: Adolescent; Adult; Alleles; Aspartic Acid; Black People; Child; Diabetes Mellitus, Type 1; Female; G

1995
Role of HLA class II alleles in Korean patients with IDDM.
    Diabetes research and clinical practice, 1996, Volume: 31, Issue:1-3

    Topics: Adult; Alleles; Arginine; Aspartic Acid; Diabetes Mellitus, Type 1; Disease Susceptibility; Genes, M

1996
Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia.
    Diabetes care, 1997, Volume: 20, Issue:6

    Topics: Adult; Aspartic Acid; Atrophy; Blood Glucose; Brain; Cerebral Cortex; Choline; Cognition; Cohort Stu

1997
MHC class II Ab diabetogenic residue 57 Asp/non-Asp dimorphism influences T-cell recognition and selection.
    Immunogenetics, 1998, Volume: 47, Issue:3

    Topics: Amino Acid Sequence; Animals; Antibodies; Arginine; Aspartic Acid; Cells, Cultured; Diabetes Mellitu

1998
Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
    Human immunology, 1997, Volume: 57, Issue:2

    Topics: Adolescent; Adult; Alleles; Aspartic Acid; Autoantibodies; Child; Diabetes Mellitus, Type 1; Haploty

1997
MR imaging and proton MR spectroscopy in A-to-G substitution at nucleotide position 3243 of leucine transfer RNA.
    AJNR. American journal of neuroradiology, 1998, Volume: 19, Issue:2

    Topics: Adult; Amino Acid Substitution; Aspartic Acid; Basal Ganglia; Base Sequence; Brain; Cerebral Cortex;

1998
The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
    International immunology, 1998, Volume: 10, Issue:8

    Topics: Alanine; Alleles; Aspartic Acid; B-Lymphocytes; Binding Sites; Cell Line; Computer Simulation; Diabe

1998
The P9 peptide sidechain specificity of I-Ad.
    Immunology letters, 1999, Dec-01, Volume: 70, Issue:3

    Topics: Animals; Antigen Presentation; Aspartic Acid; Capsid; Capsid Proteins; Cross Reactions; Diabetes Mel

1999
A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.
    Science (New York, N.Y.), 2000, Apr-21, Volume: 288, Issue:5465

    Topics: Alleles; Amino Acid Motifs; Amino Acid Sequence; Animals; Aspartic Acid; Crystallography, X-Ray; Dia

2000
Beta 57-Asp plays an essential role in the unique SDS stability of HLA-DQA1*0102/DQB1*0602 alpha beta protein dimer, the class II MHC allele associated with protection from insulin-dependent diabetes mellitus.
    Journal of immunology (Baltimore, Md. : 1950), 2000, Sep-15, Volume: 165, Issue:6

    Topics: Alleles; Amino Acid Substitution; Antigens, Differentiation, B-Lymphocyte; Aspartic Acid; Cell Line,

2000
Contribution of the absence of aspartic acid at position 57 of the HLA-DQ beta chain to predisposition to insulin-dependent diabetes mellitus in a southern Chinese population.
    Chinese medical journal, 1998, Volume: 111, Issue:8

    Topics: Adolescent; Adult; Alleles; Asian People; Aspartic Acid; Child; Child, Preschool; Diabetes Mellitus,

1998
Type 1 diabetes environmental factors and correspondence analysis of HLA class II genes in the Yemenite Jewish community in Israel.
    Diabetes care, 2001, Volume: 24, Issue:4

    Topics: Adult; Aged; Alleles; Animals; Aspartic Acid; Cattle; Diabetes Mellitus, Type 1; Emigration and Immi

2001
Genetic analysis of HLA class II alleles and susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects.
    Diabetologia, 1992, Volume: 35, Issue:5

    Topics: Alleles; Amino Acid Sequence; Aspartic Acid; Base Sequence; Diabetes Mellitus, Type 1; Gene Frequenc

1992
Susceptibility to type 1 (insulin-dependent) diabetes mellitus in Spanish patients correlates quantitatively with expression of HLA-DQ alpha Arg 52 and HLA-DQ beta non-Asp 57 alleles.
    Diabetologia, 1992, Volume: 35, Issue:6

    Topics: Alleles; Arginine; Aspartic Acid; Base Sequence; Cells, Cultured; Diabetes Mellitus, Type 1; Disease

1992
Exclusive HLA-DQ factors do not explain susceptibility to insulin-dependent diabetes.
    Human immunology, 1991, Volume: 31, Issue:2

    Topics: Alleles; Arginine; Aspartic Acid; Diabetes Mellitus, Type 1; DNA Probes; Histocompatibility Testing;

1991
Aspartic acid at position 57 of the HLA-DQ beta chain in insulin-dependent diabetes mellitus: an association with one DRw9-DQw9 subtype in the Chinese population.
    Tissue antigens, 1991, Volume: 37, Issue:5

    Topics: Alleles; Asian People; Aspartic Acid; Base Sequence; China; Diabetes Mellitus, Type 1; Disease Susce

1991
HLA-DQB1 alleles and absence of Asp 57 as susceptibility factors of IDDM in Finland.
    Diabetes, 1991, Volume: 40, Issue:12

    Topics: Adolescent; Alleles; Amino Acid Sequence; Aspartic Acid; Base Sequence; Diabetes Mellitus, Type 1; D

1991
Prevalence of HLA-DQ beta chain non-Asp alleles in type I (insulin-dependent) diabetics with young and older ages of onset.
    Klinische Wochenschrift, 1991, Oct-02, Volume: 69, Issue:15

    Topics: Adolescent; Adult; Alleles; Aspartic Acid; Chi-Square Distribution; Child; Child, Preschool; Diabete

1991
Aspartic acid at position 57 of the HLA-DQ beta chain is not protective against insulin-dependent diabetes mellitus in Japanese people.
    Journal of autoimmunity, 1990, Volume: 3, Issue:2

    Topics: Amino Acids; Aspartic Acid; Base Sequence; Diabetes Mellitus, Type 1; HLA-DQ Antigens; Humans; Japan

1990
Different amino acids at position 57 of the HLA-DQ beta chain associated with susceptibility and resistance to IgA deficiency.
    Nature, 1990, Sep-20, Volume: 347, Issue:6290

    Topics: Amino Acid Sequence; Aspartic Acid; Diabetes Mellitus, Type 1; Disease Susceptibility; Genetic Marke

1990
Aspartic acid at position 57 of the HLA-DQ beta chain is protective against future development of insulin-dependent (type 1) diabetes mellitus.
    Klinische Wochenschrift, 1991, Feb-26, Volume: 69, Issue:4

    Topics: Adult; Amino Acid Sequence; Aspartic Acid; Autoantibodies; Diabetes Mellitus, Type 1; Female; Geneti

1991
Direct evidence for the contribution of the unique I-ANOD to the development of insulitis in non-obese diabetic mice.
    Nature, 1990, Jun-21, Volume: 345, Issue:6277

    Topics: Animals; Aspartic Acid; Base Sequence; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; F

1990
High frequency of aspartic acid at position 57 of HLA-DQ beta-chain in Japanese IDDM patients and nondiabetic subjects.
    Diabetes, 1990, Volume: 39, Issue:2

    Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Asian People; Aspartic Acid; Base Sequence; Chromosome

1990
HLA-DQB 1 codon 57 and genetic susceptibility to type 1 (insulin-dependent) diabetes mellitus in French children.
    Diabetologia, 1990, Volume: 33, Issue:3

    Topics: Alanine; Alleles; Aspartic Acid; Child; Codon; Diabetes Mellitus, Type 1; France; Gene Frequency; Ge

1990
Aspartic acid at position 57 of DQ beta chain does not protect against type 1 (insulin-dependent) diabetes mellitus in Japanese subjects.
    Diabetologia, 1989, Volume: 32, Issue:10

    Topics: Aspartic Acid; Base Sequence; Diabetes Mellitus, Type 1; Genes, MHC Class II; Genetic Predisposition

1989
HLA-DQ beta non-ASP-57 allele and incidence of diabetes in China and the USA.
    Lancet (London, England), 1989, Aug-26, Volume: 2, Issue:8661

    Topics: Alleles; Aspartic Acid; China; Chromosome Mapping; Diabetes Mellitus, Type 1; Disease Susceptibility

1989
The amino acid at position 57 of the HLA-DQ beta chain and susceptibility to develop insulin-dependent diabetes mellitus.
    Human immunology, 1989, Volume: 26, Issue:3

    Topics: Adolescent; Alleles; Amino Acid Sequence; Aspartic Acid; Base Sequence; Diabetes Mellitus, Type 1; D

1989
The 57th variety.
    Scientific American, 1988, Volume: 258, Issue:1

    Topics: Amino Acid Sequence; Animals; Aspartic Acid; Diabetes Mellitus, Type 1; Genetic Therapy; HLA-DQ Anti

1988
Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study.
    Proceedings of the National Academy of Sciences of the United States of America, 1988, Volume: 85, Issue:21

    Topics: Aspartic Acid; Base Sequence; Codon; Diabetes Mellitus, Type 1; Disease Susceptibility; Female; Hapl

1988